Chemistry: natural resins or derivatives; peptides or proteins; – Proteins – i.e. – more than 100 amino acid residues – Blood proteins or globulins – e.g. – proteoglycans – platelet...
Patent
1995-06-06
2000-03-14
Johnson, Nancy A.
Chemistry: natural resins or derivatives; peptides or proteins;
Proteins, i.e., more than 100 amino acid residues
Blood proteins or globulins, e.g., proteoglycans, platelet...
5303882, 53038822, 53038873, 53038875, 53038885, C07K 1618, C07K 1628, C07K 1644
Patent
active
060374535
ABSTRACT:
Two classes of polypeptides derived from human IgE are described. One class binds selectively to the high affinity IgE receptor on mast cells and basophils, but not to the low affinity IgE receptor on B-cells, monocytes, eosinophils and platelets. The other class binds to the low affinity receptor, but not the high affinity receptor. The differential binding polypeptides of this invention are useful in diagnostic procedures for IgE receptors or in the therapy of IgE-mediated disorders such as allergies. They also are useful in preparing antibodies capable of binding regions of IgE that participate in receptor binding.
REFERENCES:
patent: 4714759 (1987-12-01), Whitaker, Jr.
patent: 4861579 (1989-08-01), Meyer et al.
patent: 4940782 (1990-07-01), Rup et al.
patent: 5428133 (1995-06-01), Chang
M. Sung Co, Nature 351:501, 1991.
Emery, Exp. Opin Invest. Drugs 3(3):241, 1994.
Williams G. 1988. Trends in Biotechnology, 2, 36-42.
Baniyash et al., "Anti-IgE monoclonal antibodies directed at the Fc.sub..epsilon. receptor binding site" Molecular Immunology 25(8):705-711 (1988).
Baniyash et al., "Inhibition of IgE binding to mast cells and basophils by monoclonal antibodies to murine IgE" European Journal of Immunology 14:799-807 (1984).
Burgess et al., "Possible Dissociation of the Heparin-binding and Mitogenic Activities of Heparin-binding (Acidic Fibroblast) Growth Factor-1 from Its Receptor-binding Activities by Site-directed Mutagenesis of a Single Lysine Residue" Journal of Cell Biology 111:2129-2138 (1990).
Burt et al., "Analysis of the interaction between rat immunoglobulin E and rat mast cells using anti-peptide antibodies" Molecular Immunology 24(4):379-389 (1987).
Burt et al., "Inhibition of binding rat IgE to rat mast cells by synthetic IgE peptides" European Journal of Immunology 17:437-440 (1987).
Conrad et al., "The interaction of human and rodent IgE with the human basophil IgE receptor" J. of Immunology 130(1):3273-333 (1983).
Conrad, D.H., "Fc.epsilon.RII/CD23: The low affinity receptor for IgE" Ann. Rev. Immunol. 8:623-645 (1990).
Disenhofer, "Crystallographic refinement and atomic models of a human Fc fragment and its complex with fragment of protein a from Staphylococcus aureus at 2.9- and 2.8-A resolution" Biochemistry 20(9):2361-2370 (1981).
Geha et al., "IgE sites relevant for binding to type 1 Fc .epsilon. (FCER) receptors on mast cells" J. Allergy & Clin. Immunol. (abstract) 79(1):129 (1987).
Gleenie et al. J. Immunol. 139(7):2367 (1987).
Hakimi et al., "The .alpha. subunit of the human IgE receptor (FcERI) is sufficient for high affinity IgE binding" Journal of Biological Chemistry 265(3):22079-22081 (1990).
Helm et al., "Blocking of passive sensitization of human mast cells and basophil granulocytes with IgE antibodies by a reconbinant human .epsilon. chain fragment of 76 amino acids" Proc. Natl. Acad. Sci. 86:9465-9469 (1989).
Helm et al., "The mast cell binding site on human immunoglobulin E" Nature 331:180-183 (1988).
Hoffman, D. R., "Enzyme-linked immunosorbent assays (ELISA) for immunoglobulin E and blocking antibodies" Methods in Enzymology, Chapter 45, 73:656-666 (1981).
Hook et al., "Monoclonal Antibodies Defining Epitopes on Human IgE" Molecular Immunology 28(6):631-639.
Ishizaka, K., "Immunoglobulin E (IgE)" Methods in Enzymology 116 (Part II):76-94 (1985).
Kabat Sequence of Proteins of Immunological Intent, 4th edition pp. 41-42, 167-168 (1987).
Kinet et al., "How Antibodies Work: Focus on Fc Receptors" FASEB J. 2(1):14-17 (1988).
Kulczycki et al., "The interaction of IgE with rat basophilic leukemia cells I. Evidence for specific binding of IgE" Journal of Experimental Medicine 139:600-616 (1974).
Kurokawa et al., "Expression of human immunoglobulin .epsilon. chain cDNA om E coli" Nucleic Acids Research 11(10):3077-3085 (1983).
Lazar et al., "Transforming Growth Factor .alpha.: Mutation of Aspartic Acid 47 and Leucine 48 Results in Different Biological Activities" Moelcular & Cellular Biology 8(3):1247-1252 (1988).
Liu et al., "Expression of a biologically active fragment of human IgE .epsilon. chain in Escherichia coli" Proc. Natl. Acad. Sci. 81:5369-5373 (1984).
Metzger et al., "How antibodies work: focus on Fc receptors" FASEB J. 2(1):3-11 (1988).
Neurath, A. R., "Use of .sup.125 I-labeled anti-2,4-dinitrophenyl (DNP) antibodies as a general tracer in solid-phase radioimmunoassays" Methods in Enzymology 73:127-138 (1981).
Nio et al., "Inhibition of histamine release by synthetic human IgE peptide fragments: structure-activity studies" Peptide Chemistry pp. 203-208 (1989).
Nissim et al., "Mapping of the high affinity Fc .epsilon. receptor binding site to the third constant region domain of IgE" EMBO Journal 10(1):101-107 (Jan. 1991).
Nitta et al., "Preliminary trial of specific targeting therapy against malignant glioma" Lancet 355(8686):368-371 (Feb. 17, 1990).
Padlan et al., "A model of the Fc of immunoglobulin E" Molecular Immunology 23(10):1063-1075 (1986).
Queen et al., "A humanized antibody that binds to the interleukin 2 receptor" Proc. Natl. Acad. Sci. USA 86(24):10029-10033 (1989).
Riske et al., "High affinity human IgE receptor (Fc .epsilon. RI). Analysis of functional domains of the .alpha.-subunit with monoclonal antibodies" Journal of Biological Chemistry 266(17):1124-1125 (Jun. 15, 1991).
Robertson et al., "IgE structure-function relationships defined by sequence directed antibodies induced by synthetic peptides" Molecular Immunology 25(2):103-113 (1988).
Schwarzbaum et al., "Mapping of murine IgE epitopes involved in IgE-Fc.epsilon. receptor interactions" European Journal of Immunology 19:1015-1023 (1989).
Stanworth et al., "Synthetic peptides comprising sequences of the human immunoglobulin E heavy chain capable of releasing histamine" Biochemical Journal 180(3):665-668 (1979).
Stanworth et al., "The use of synthetic peptides in the delineation of immunoglobulin antigenic epitopes and Fc effectorfunctions" CIBA Found. Symp. 119:226-244 (1986).
Tao et al., "Role of Carbohydrate in the Structure and Effector Functions Mediated by the H uman IgE Constant Region" J. Immunol. 143(8):2595-2601 (1989).
Tung, A. S., "Production, purification, and characterization of antigen-specific murine monoclonal antibodies of IgE class" Methods in Enzymology, Chapter 6, 92:47-66 (1983).
Vercelli et al., "The B-cell binding site on human immunoglobulin E" Nature 338:649-651 (1989).
Weetall et al., "Mapping the site of interaction between murine IgE and its high affinity receptor with chimeric Ig" J-Immunol 145(11):3849-3854 (Dec. 1, 1990).
Jardieu Paula M.
Presta Leonard G.
Genentech Inc.
Johnson Nancy A.
Svoboda Craig G.
LandOfFree
Immunoglobulin variants does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Immunoglobulin variants, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Immunoglobulin variants will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-170424